R. Jayachandra Babu

Amorphous-State Characterization of Efavirenz—Polymer Hot-Melt Extrusion Systems for Dissolution Enhancement

Sateesh Kumar Sathigari, Vinod K. Radhakrishnan, Virginia A. Davis et al. · Journal of Pharmaceutical Sciences · 2012 · 133 citations · Full text

Materials Science, Dissolution Enhancement, Engineering +7

Physicochemical Characterization of Efavirenz–Cyclodextrin Inclusion Complexes

Sateeshkumar Sathigari, Gurkishan Chadha, Y-H. Phillip Lee et al. · AAPS PharmSciTech · 2009 · 102 citations · Full text

Molecular Complex, Efavirenz–cyclodextrin Inclusion Complexes, Biomolecular Engineering +1

In vitro and in vivo evaluation of topical formulations of Spantide II

Loice Kikwai, R. Jayachandra Babu, Renata Prado et al. · AAPS PharmSciTech · 2005 · 80 citations · Full text

Topical Formulations, Vivo Evaluation, Medicine +5

Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus

Ranjeet Prasad Dash, R. Jayachandra Babu, Nuggehally R. Srinivas · Xenobiotica · 2016 · 77 citations

Translational Medicine, Diabetes Management, α-Glucosidase Inhibitors +12

Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin

R. Jayachandra Babu, J. K. Pandit · International Journal of Pharmaceutics · 2003 · 69 citations

Rat Skin, Pharmaceutical Science, Transdermal Delivery +6